Ragan Paula's Form 4 filing
X4 Pharmaceuticals, Inc (XFOR) · filed Nov 19, 2024
- Accession no.
- 0001628280-24-048467
- Filed
- Nov 19, 2024, 4:31 PM ET
- Trade date
- Nov 15, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $12.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ragan PaulaCIK 0001769914 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | Common Stock | SSaleDisposed | −31,897 | $0.3945 | −$12,583.37 | 993,919 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.